Up-regulation of thy-1 promotes invasion and metastasis of hepatocarcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1349-1353

  Cheng, Bian Qiao ^a   Jiang, Yi ^a   Li, Dong Liang ^a   Fan, Jing Jing ^a   Ma, Ming ^a  

^a FUZHOU GENERAL HOSPITAL   (China)

Author keywords

Hepatocarcinomas; Invasion; Migration; Thy 1

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA FETOPROTEIN; CADHERIN; THY 1 ANTIGEN;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CARCINOMA; CELL DIFFERENTIATION; CELL STRAIN HEPG2; CHI SQUARE DISTRIBUTION; DRUG EFFECT; GENETIC TRANSFECTION; HUMAN; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; UPREGULATION;

ALPHA-FETOPROTEINS; ANALYSIS OF VARIANCE; ANTIGENS, THY-1; ASPIRIN; CADHERINS; CARCINOMA; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; TRANSFECTION; UP-REGULATION;

EID: 84873043864     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1349     Document Type: Article

References (35)

1. Alison MR (2005). Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev, 1, 253-60.
2. Alison MR (2006). Liver cancer: a disease of stem cells? Panminerva Med, 48, 165-74.
3. Alison MR, Islam S, Lim S (2009). Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. I, 217, 282-98.
4. Bird TG, Lorenzini S, Forbes SJ (2008). Activation of stem cells in hepatic diseases. Cell Tissue Res, 331, 283-300.
5. Ceafalan L, Vidulescu C, Radu E, et al (2005). Expression of stem cell markers on fetal and tumoral human liver cells in primary culture. Rev Med Chir Soc Med Nat Iasi, 109, 96-104.
6. Chen JF, Zhang LJ, Zhao AL, et al (2005). Abnormal expression of Thy-1 as a novel tumor marker in lung cancer and its prognostic significance, Zhong Hua Yi Xue Za Zhi, 85, 1921-5.
7. Chiba T, Kamiya A, Yoksuka O, et al (2009). Cancer stem cells in hepatocellular carcinoma: Recent progess and perspective. Cancer lett, 286, 145-53.
8. Couzin J (2003). Medicine. Tracing the steps of metastasis, cancer's menacing ballet. Science, 299, 1002-6.
9. Czyzewska J, Guzińska-Ustymowicz K, Ustymowicz M (2010). The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis. Folia Histochem Cytobiol, 48, 37-45.
10. Dahlke MH, Popp FC, Bahlmann FH, et al (2003). Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute? J Hepatol, 39, 365-73.
11. Dihlmann S, Klein S, Doeberitz Mv MK, et al (2003). Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin. Mol Cancer Ther, 2, 509-16.
12. DiMmann S, Siermann A, Von Knebel Doebefitz M (2001). The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Oncogene, 20, 645-53.
13. Donnenberg VS, Donnenberg AD, Zimmerlin L (2010). Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom, 78, 287-301.
14. Fromowitz FB, Viola MV, Chao S, et al (1987). Ras p21 expression inthe progression of breast cancer. Hum Pathol, 18, 1268-75
15. Jawhari A, JordanS, Pooles, et al (1997). Abnormal immunoreactivitythe E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology, 112, 46-54.
16. Kang XQ, Zang WJ, Bao LJ, et al (2006). Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro. Cell Biol Int, 30, 569-75.
17. Kuhlmann WD, Peschke P (2006). Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int J Exp Pathol, 87, 343-59.
18. Lee TK, Castilho A, Ma S, et al (2009). Liver cancer stem cells: implications for a new therapeutic target. Liver Int, 29, 955-65.
19. Masson NM, Currie IS, Terrace JD, et al (2006). Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1. Am J Physiol Gastrointest Liver Physiol, 291, G45-54.
20. Mercati F, Pascucci L, Ceccarelli P, et al (2009). Expression of mesenchymal stem cell marker CD90 on dermal sheath cells of the anagen hair follicle in canine species. Eur J Histochem. 53,159-66.
21. Nieset J E, Redfield AR, Jin F, et al (1997). Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin. Cell Sci, 110, 1013-22.
22. Okabe M, Tsukahara Y, Tanaka M, et al (2009). Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development, 136, 1951-60.
23. Rege TA, Hagood JS (2006). Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J, 20, 1045-54.
24. Rege TA, Hagood JS (2006). Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta, 1763, 991-9.
25. ReyaT, MorrisonSJ, ClarkeMF, et al (2001). Stemcellscancerstemcells. Nature, 414, 105-11.
26. Sell S, Leffert HL (2008). Liver cancer stem cells. J Clin Oncol, 26, 2800-5.
27. Shupe T, Petersen BE (2005). Evidence regarding a stem cell origin of hepatocellular carcinoma. Stem Cell Rev, 1, 261-4.
28. Shupe TD, Piscaglia AC, Oh SH, et al (2009). Isolation and characterization of hepatic stem cells, or "oval cells," from rat livers. Methods Mol Biol, 482, 387-405.
29. Strick-Marchand H, Masse GX, Weiss MC, et al (2008). Lymphocytes support oval cell-dependent liver regeneration. J Immunol, 181, 2764-71.
30. True LD, Zhang H, Ye M, et al (2010). CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Mod Pathol, 23, 1346-56.
31. Wu XZ, Chen D (2006). Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol, 21, 1093-8.
32. Xu W, Cao L, Yin ZF (2009). Progress and prospects in cancer stem cell research for hepatocellular carcinoma. Chin J Cancer, 28, 1004-8.
33. Yamazaki H, Nishida H (2009). Iwata S CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. Biochem Biophys Res Commun, 383, 172-7.
34. Yang ZF, Ho DW, Ng MN, et al (2008). Significance of CD90+ cancer stem cells in human liver cancer. Hepatology, 47, 2136-7.
35. Yang ZF, Ngai P, Ho DW, et al (2008). Identification of local and circulating cancer stem cells in human liver cancer. Hepatology, 47, 919-28